Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.
Cellbricks Therapeutics has raised $8.1M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
Cellbricks Therapeutics's investors include VU Venture Partners, ACT Venture Partners, SPRIN-D, Silicon Roundabout Ventures, b.value AG.
Cellbricks Therapeutics is headquartered in Berlin, Germany.
Cellbricks is a Berlin- and Boston-based biotech, pioneering the future of tissue and organ replacement.
Cellbricks Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Cellbricks Therapeutics — Funding & Investors." VCBacked, March 25, 2026, https://www.vcbacked.co/company/cellbricks-therapeutics. Accessed August 1, 2026.
VCBacked. (2026). Cellbricks Therapeutics — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/cellbricks-therapeutics
{{cite web |title=Cellbricks Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/cellbricks-therapeutics |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated